IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma. - Archive ouverte HAL Access content directly
Journal Articles Blood Year : 2012

IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma.

(1) , (2) , (3, 4) , (2) , (5) , (6) , (7) , (8) , (9) , (10, 11) , (12) , (2) , (3, 4) , (1)
1
2
3
4
5
6
7
8
9
10
11
12

Abstract

Mutations in isocitrate dehydrogenase 1 (IDH1) and isocitrate dehydrogenase 2 (IDH2) occur in most grade 2 and 3 gliomas, secondary glioblastomas, and a subset of acute myelogenous leukemias but have not been detected in other tumor types. The mutations occur at specific arginine residues and result in the acquisition of a novel enzymatic activity that converts 2-oxoglutarate to D-2-hydroxyglutarate. This study reports IDH1 and IDH2 genotyping results from a set of lymphomas, which included a large set of peripheral T-cell lymphomas. IDH2 mutations were identified in approximately 20% of angioimmunoblastic T-cell lymphomas (AITLs), but not in other peripheral T-cell lymphoma entities. These results were confirmed in an independent set of AITL patients, where the IDH2 mutation rate was approximately 45%. This is the second common genetic lesion identified in AITL after TET2 and extends the number of neoplastic diseases where IDH1 and IDH2 mutations may play a role.
Fichier principal
Vignette du fichier
inserm-00689602_edited.pdf (141.45 Ko) Télécharger le fichier
Vignette du fichier
Cairns_Blood_AITL_final_with_fig_and_supp.pdf (478.69 Ko) Télécharger le fichier
Origin : Files produced by the author(s)
Origin : Files produced by the author(s)
Loading...

Dates and versions

inserm-00689602 , version 1 (03-07-2012)

Identifiers

Cite

Rob A. Cairns, Javeed Iqbal, François Lemonnier, Can Kucuk, Laurence de Leval, et al.. IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma.: IDH2 mutations in AITL. Blood, 2012, 119 (8), pp.1901-3. ⟨10.1182/blood-2011-11-391748⟩. ⟨inserm-00689602⟩
200 View
908 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More